These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 4470244)
21. Toward a biochemical classification of depression. van Praag HM Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704 [No Abstract] [Full Text] [Related]
22. Therapy-resistant depressions. Biochemical and pharmacological considerations. Contributions to biochemistry. van Praag HM Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):88-98. PubMed ID: 4438429 [No Abstract] [Full Text] [Related]
23. [Tryptophan metabolism during depression]. Mangoni A Riv Sper Freniatr Med Leg Alien Ment; 1968 Aug; 92(4):1109-18. PubMed ID: 5738061 [No Abstract] [Full Text] [Related]
24. Deductive approaches to the catecholamine hypothesis of affective disorders. Wittenborn JR J Nerv Ment Dis; 1974 May; 158(5):320-4. PubMed ID: 4823932 [No Abstract] [Full Text] [Related]
27. The chemical pathology of the affective disorders. Coppen AJ Sci Basis Med Annu Rev; 1970; ():179-210. PubMed ID: 4922946 [No Abstract] [Full Text] [Related]
28. [Comparative effectiveness of various tricyclic antidepressive agents in ischemic heart disease]. Zaĭtsev VP; Kol'tsova TI Klin Med (Mosk); 1977 Sep; 55(9):114-8. PubMed ID: 562955 [No Abstract] [Full Text] [Related]
29. 5-Hydroxytryptamine in depression. Pare CM; Trenchard A; Turner P Adv Biochem Psychopharmacol; 1974; 11(0):275-9. PubMed ID: 4846267 [No Abstract] [Full Text] [Related]
30. [Neuromediators and anhedonia]. Ammar S Encephale; 1998 Jul; 24 Spec No 1():31-3. PubMed ID: 9809252 [No Abstract] [Full Text] [Related]
31. Amitriptyline in emotional states at the menopause. Kerr MM N Z Med J; 1970 Oct; 72(461):243-5. PubMed ID: 4922592 [No Abstract] [Full Text] [Related]
32. Is impaired neurogenesis relevant to the affective symptoms of depression? Sapolsky RM Biol Psychiatry; 2004 Aug; 56(3):137-9. PubMed ID: 15271580 [No Abstract] [Full Text] [Related]
34. [Tryptophan and catecholamine metabolism in affective disturbances]. Puzyński S; Bidziński A; Hauptmann M; Rode A; Jakimow-Venulet B; Załuska M Psychiatr Pol; 1978; 12(3):301-9. PubMed ID: 693698 [No Abstract] [Full Text] [Related]
35. [Double-blind study on 3 antidepressive agents. 2. Clinical comparison of noxiptiline, nor-noxiptiline, and amitryptiline using the AMP system]. Bente D; Feder J; Belmchen H; Hippius H; Rosenberg L Arzneimittelforschung; 1973 Feb; 23(2):247-55. PubMed ID: 4573740 [No Abstract] [Full Text] [Related]
36. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Ressler KJ; Nemeroff CB Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410 [TBL] [Abstract][Full Text] [Related]
37. Pain, depression and phobia: a biochemical hypothesis. Bailey RI; Wootton LW J Int Med Res; 1976; 4(2 Suppl):73-80. PubMed ID: 16798 [No Abstract] [Full Text] [Related]
38. [Serum free tryptophan concentration--The effects on the brain serotonin metabolism and its relationship to the mental diseases-- (author's transl)]. Nakaya K Seishin Shinkeigaku Zasshi; 1976; 78(2):119-32. PubMed ID: 989910 [No Abstract] [Full Text] [Related]
39. Sources of contribution to the understanding of the etiology of mood disorders. Lipton MA; Prange AJ; Wilson IC Proc Annu Meet Am Psychopathol Assoc; 1972; 60():117-31. PubMed ID: 4621831 [No Abstract] [Full Text] [Related]
40. [Central serotonin metabolism in depression]. van Praag HM Ned Tijdschr Geneeskd; 1980 Jun; 124(24):964-71. PubMed ID: 6966766 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]